| Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 179 (4), 964-983. e31, 2019 | 488 | 2019 |
| Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35, 2020 | 464 | 2020 |
| Proteogenomic and metabolomic characterization of human glioblastoma LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ... Cancer cell 39 (4), 509-528. e20, 2021 | 390 | 2021 |
| Proteogenomic characterization of endometrial carcinoma Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ... Cell 180 (4), 729-748. e26, 2020 | 325 | 2020 |
| Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma C Huang, L Chen, SR Savage, RV Eguez, Y Dou, Y Li, ... Cancer cell 39 (3), 361-379. e16, 2021 | 218 | 2021 |
| Integrated proteogenomic characterization across major histological types of pediatric brain cancer F Petralia, N Tignor, B Reva, M Koptyra, S Chowdhury, D Rykunov, A Krek, ... Cell 183 (7), 1962-1985. e31, 2020 | 206 | 2020 |
| A proteogenomic portrait of lung squamous cell carcinoma S Satpathy, K Krug, PMJ Beltran, SR Savage, F Petralia, C Kumar-Sinha, ... Cell 184 (16), 4348-4371. e40, 2021 | 190 | 2021 |
| Estimation of causal effects of multiple treatments in observational studies with a binary outcome L Hu, C Gu, M Lopez, J Ji, J Wisnivesky Statistical methods in medical research 29 (11), 3218-3234, 2020 | 62 | 2020 |
| Estimating heterogeneous survival treatment effect in observational data using machine learning L Hu, J Ji, F Li Statistics in medicine 40 (21), 4691-4713, 2021 | 51 | 2021 |
| Programmed death-1 or programmed death ligand-1 blockade in patients with platinum-resistant metastatic urothelial cancer: a systematic review and meta-analysis SA Niglio, R Jia, J Ji, S Ruder, VG Patel, A Martini, JP Sfakianos, ... European Urology 76 (6), 782-789, 2019 | 42 | 2019 |
| Prospective cohort study to investigate the safety of preoperative tumor necrosis factor inhibitor exposure in patients with inflammatory bowel disease undergoing intra … BL Cohen, P Fleshner, SV Kane, HH Herfarth, N Palekar, FA Farraye, ... Gastroenterology 163 (1), 204-221, 2022 | 41 | 2022 |
| Longitudinal autonomic nervous system measures correlate with stress and ulcerative colitis disease activity and predict flare RP Hirten, M Danieletto, R Scheel, M Shervey, J Ji, L Hu, J Sauk, L Chang, ... Inflammatory bowel diseases 27 (10), 1576-1584, 2021 | 37 | 2021 |
| Clinical proteomic tumor analysis consortium. Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 179 (4), 964-983, 2019 | 36 | 2019 |
| Tree‐based machine learning to identify and understand major determinants for stroke at the neighborhood level L Hu, B Liu, J Ji, Y Li Journal of the American Heart Association 9 (22), e016745, 2020 | 31 | 2020 |
| Insights into impact of DNA copy number alteration and methylation on the proteogenomic landscape of human ovarian cancer via a multi-omics integrative analysis X Song, J Ji, KJ Gleason, F Yang, JA Martignetti, LS Chen, P Wang Molecular & Cellular Proteomics 18 (8), S52-S65, 2019 | 31 | 2019 |
| Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease RC Ungaro, L Hu, J Ji, S Nayar, S Kugathasan, LA Denson, J Hyams, ... Alimentary pharmacology & therapeutics 53 (2), 281-290, 2021 | 28 | 2021 |
| Proteogenomic data and resources for pan-cancer analysis Y Li, Y Dou, FDV Leprevost, Y Geffen, AP Calinawan, F Aguet, Y Akiyama, ... Cancer cell 41 (8), 1397-1406, 2023 | 22 | 2023 |
| Effects of school breaks on influenza-like illness incidence in a temperate Chinese region: an ecological study from 2008 to 2015 Y Chu, Z Wu, J Ji, J Sun, X Sun, G Qin, J Qin, Z Xiao, J Ren, D Qin, ... BMJ open 7 (3), e013159, 2017 | 21 | 2017 |
| Post-anticoagulant D-dimer is a highly prognostic biomarker of COVID-19 mortality X Song, J Ji, B Reva, H Joshi, AP Calinawan, M Mazumdar, ... ERJ open research 7 (3), 2021 | 20 | 2021 |
| Validation of melanoma immune profile (MIP), a prognostic immune gene prediction score for stage II–III melanoma RD Gartrell, DK Marks, EM Rizk, M Bogardus, CL Gérard, LW Barker, Y Fu, ... Clinical Cancer Research 25 (8), 2494-2502, 2019 | 20 | 2019 |
